Sufferers that are quick cytochrome P-450 2D6 metabolizers encounter a much better tramadol opioid response and therefore are at a heightened possibility for abusing or overdosing with tramadol. As a result, clinicians are inspired to consider utilizing pharmacogenetic tests to predict an individual’s response, threat of habit, and therefore the